Prakt. lékáren. 2016; 12(4): 138-142 | DOI: 10.36290/lek.2016.033

Overview of the effects and safety of the use of natural medicines during pregnancy and lactation - part 5

Lenka Tůmová, Lenka Holcová
Katedra farmakognozie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova v Praze

The subscription continues in previous paper „Danger of medicinal plants used in pregnancy and breast-feeding period“. Therapeutic

use, side effects and categorization of safety drug use in pregnancy and in breast-feeding period are shown in the form of tables

in individual drugs (alphabetic order-letter H-L). There are also mentioned the results of animal study models and human models.

Keywords: pregnancy, breast-feeding, medicinal plant drug

Published: September 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tůmová L, Holcová L. Overview of the effects and safety of the use of natural medicines during pregnancy and lactation - part 5. Praktické lékárenství. 2016;12(4):138-142. doi: 10.36290/lek.2016.033.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mills S, Bone K. The Essential Guide To Herbal Safety, Elsevier Churchill Livingstone, 2005.
    2. Mahomed IM, Ojewole JA. Uterotonic effect of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract on rat isolated uterine horns, J. Smooth. Muscle. Res. 2009; 45(5): 231-239. Go to original source... Go to PubMed...
    3. Yao M, Ritchie HE, Brown-Woodman PD. A reproductive scanning test of goldenseal, Birth Defects Res. B., Dev. Reprod. Toxicol. 2005; 74: 399-404. Go to original source... Go to PubMed...
    4. Dugogua JJ, Mills E, Perri D, Koren G. Safety and Efficacy of St. Johns wort (Hypericum) during Pregnancy and Lactation, Can. J. Clin. Pharmacol. 2006; 13(3): 268-276.
    5. Juszkiewicz T, Minta., Wlodarczyk B, Biernacki B. Teratological evaluation of Ukrain in hamsters and rats, Drugs Exp. Clin. Res. 1992; 18: 23-29.
    6. Guerra M de O, Mazoni AS, Brand?o MA, Peters VM. Toxicology of Lapachol in rats: embryolethality, Braz. J. Biol. 2001; 61(1): 171-174. Go to original source... Go to PubMed...
    7. Felício AC, Chang CV, Brand?o MA, Peters VM, Guerra M de O. Fetal growth in rats treated with lapachol, Contraception. 2002; 66(4): 289-293. Go to original source... Go to PubMed...
    8. Guerra MO, Mazoni AS, Brand?o MA, Peters VM. Interceptive effect of Lapachol in rats, Contraception. 1999; 60(5): 305-307. Go to original source... Go to PubMed...
    9. Strandberg TE, Andersson S, Järvenpää AL, McKeigue PM. Preterm birth and licorice consumption during pregnancy, Am. J. Epidemiol. 2002; 156(9): 803. Go to original source... Go to PubMed...
    10. Strandberg TE, Järvenpää AL, Vanhanen H, McKeigue PM. Birth outcome in relation to licorice consumption during pregnancy, Am. J. Epidemiol. 2001; 153(11): 1085-1088. Go to original source... Go to PubMed...
    11. Räikkönen K, Pesonen AK, Heinonen K, Lahti J, Komsi N, Eriksson JG, Seckl JR, Järvenpää AL, Strandberg TE. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children, Am. J. Epidemiol. 2009; 170(9): 1137-1146. Go to original source... Go to PubMed...
    12. Jahodář L. Farmakobotanika, semenné rostliny, Karolinum, Praha 2006.
    13. Hubík J, Dušek J, Spilková J, Šícha J. Obecná farmakognozie, Státní pedagogické nakladatelství, Praha 1989.
    14. Lans C, Turner N, Brauer G, Khan T. Medicinal plants used in British Columbia, Canada for reproductive health in pets, Prev. Vet. Med. 2009; 90(3-4): 268-273. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.